Phenotypic heterogeneity of primitive leukemic hematopoietic cells in patients with chronic myeloid leukemia - PubMed (original) (raw)
. 1992 Nov 15;80(10):2522-30.
Affiliations
- PMID: 1384787
Free article
Phenotypic heterogeneity of primitive leukemic hematopoietic cells in patients with chronic myeloid leukemia
C Udomsakdi et al. Blood. 1992.
Free article
Abstract
The peripheral blood of chronic myeloid leukemia (CML) patients with chronic-phase disease and elevated white blood cell (WBC) counts typically contains markedly increased numbers of a variety of neoplastic pluripotent and lineage-restricted hematopoietic progenitors. These include cells detected in standard colony assays as well as their more primitive precursors. The latter are referred to as long-term culture-initiating cells (LTC-IC) because of their ability to generate clonogenic cell progeny detectable after a minimum of 5 weeks incubation on competent fibroblast feeder layers. In this study, we have investigated a number of the properties of the LTC-IC and clonogenic cells present in the blood of such CML patients with high WBC counts. This included an analysis of the light scattering properties of these progenitors, as well as their expression of CD34 and HLA-DR, Rhodamine-123 staining, and in vitro sensitivity to 4-hydroperoxycyclophosphamide. In the case of LTC-IC, the production of different types of lineage-restricted and multipotent progeny was also analyzed. Most of the circulating LTC-IC and clonogenic cells in the CML patients studied (on average approximately 70% and approximately 90%, respectively) showed features of proliferating or activated cells. This is in marked contrast to the majority of progenitors in the blood of normal individuals and most of the LTC-IC in normal marrow, all of which exhibit a phenotype expected of quiescent cells. Interestingly, a significant proportion of the circulating clonogenic cells and LTC-IC in the CML samples studied (on average approximately 10% and approximately 30%, respectively) appeared to be phenotypically similar to normal circulating progenitors, although their absolute numbers were indicative of a neoplastic origin. Both phenotypes of circulating CML clonogenic cells and LTC-IC could be obtained at approximately 10% to 20% purity by differential multiparameter sorting. These findings suggest that expansion of the Philadelphia chromosome-positive clone at the level of the earliest types of hematopoietic cells results from the activation of mechanisms that enable some, but not all, signals that block the cycling of normal stem cells to be bypassed or overcome. In addition, they provide strategies for purifying these primitive leukemic cells that should facilitate further analysis of the mechanisms underlying their abnormal proliferative behavior.
Similar articles
- Characterization of primitive hematopoietic cells in normal human peripheral blood.
Udomsakdi C, Lansdorp PM, Hogge DE, Reid DS, Eaves AC, Eaves CJ. Udomsakdi C, et al. Blood. 1992 Nov 15;80(10):2513-21. Blood. 1992. PMID: 1384786 - Rapid decline of chronic myeloid leukemic cells in long-term culture due to a defect at the leukemic stem cell level.
Udomsakdi C, Eaves CJ, Swolin B, Reid DS, Barnett MJ, Eaves AC. Udomsakdi C, et al. Proc Natl Acad Sci U S A. 1992 Jul 1;89(13):6192-6. doi: 10.1073/pnas.89.13.6192. Proc Natl Acad Sci U S A. 1992. PMID: 1631107 Free PMC article. - The biology of normal and neoplastic stem cells in CML.
Eaves C, Udomsakdi C, Cashman J, Barnett M, Eaves A. Eaves C, et al. Leuk Lymphoma. 1993;11 Suppl 1:245-53. doi: 10.3109/10428199309047894. Leuk Lymphoma. 1993. PMID: 8251904 Review. - BCR/ABL-negative primitive progenitors suitable for transplantation can be selected from the marrow of most early-chronic phase but not accelerated-phase chronic myelogenous leukemia patients.
Verfaillie CM, Bhatia R, Miller W, Mortari F, Roy V, Burger S, McCullough J, Stieglbauer K, Dewald G, Heimfeld S, Miller JS, McGlave PB. Verfaillie CM, et al. Blood. 1996 Jun 1;87(11):4770-9. Blood. 1996. PMID: 8639848 - Biological strategies for the selective manipulation of normal and leukemic stem cells.
Eaves CJ, Cashman JD, Zoumbos NC, Barnett MJ, Eaves AC. Eaves CJ, et al. Stem Cells. 1993 Oct;11 Suppl 3:109-21. doi: 10.1002/stem.5530110924. Stem Cells. 1993. PMID: 7905319 Review.
Cited by
- Ex vivo expansion of normal and chronic myeloid leukemic stem cells without functional alteration using a NUP98HOXA10homeodomain fusion gene.
Sloma I, Imren S, Beer PA, Zhao Y, Lecault V, Leung D, Raghuram K, Brimacombe C, Lambie K, Piret J, Hansen C, Humphries RK, Eaves CJ. Sloma I, et al. Leukemia. 2013 Jan;27(1):159-69. doi: 10.1038/leu.2012.196. Epub 2012 Jul 16. Leukemia. 2013. PMID: 22868969 Free PMC article. - Benign hematopoietic progenitors in chronic myeloid leukemia: current status and future prospects.
Cervantes F, Rozman C. Cervantes F, et al. Ann Hematol. 1994 Sep;69(3):99-105. doi: 10.1007/BF01695688. Ann Hematol. 1994. PMID: 8086513 Review. - Unresponsiveness of primitive chronic myeloid leukemia cells to macrophage inflammatory protein 1 alpha, an inhibitor of primitive normal hematopoietic cells.
Eaves CJ, Cashman JD, Wolpe SD, Eaves AC. Eaves CJ, et al. Proc Natl Acad Sci U S A. 1993 Dec 15;90(24):12015-9. doi: 10.1073/pnas.90.24.12015. Proc Natl Acad Sci U S A. 1993. PMID: 8265663 Free PMC article. - Unbiased phenotypic identification of functionally distinct hematopoietic progenitors.
Georgolopoulos G, Iwata M, Psatha N, Yiangou M, Vierstra J. Georgolopoulos G, et al. J Biol Res (Thessalon). 2019 Jul 18;26:4. doi: 10.1186/s40709-019-0097-7. eCollection 2019 Dec. J Biol Res (Thessalon). 2019. PMID: 31360678 Free PMC article. - Discovery of survival factor for primitive chronic myeloid leukemia cells using induced pluripotent stem cells.
Suknuntha K, Ishii Y, Tao L, Hu K, McIntosh BE, Yang D, Swanson S, Stewart R, Wang JYJ, Thomson J, Slukvin I. Suknuntha K, et al. Stem Cell Res. 2015 Nov;15(3):678-693. doi: 10.1016/j.scr.2015.10.015. Epub 2015 Oct 31. Stem Cell Res. 2015. PMID: 26561938 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials